doi: 10.1016/s0014-4835(86)80013-6
Characterization and validation of a chronic model of cyclophosphamide-induced interstitial cystitis/bladder pain syndrome in rats
No major drug interactions with GLP-1 medications are established, but individual tolerability and appropriateness should be evaluated with your healthcare provider
These findings support a role for GpoA, along with AhpD and TpxD, in enabling S
*Correspondence: Baptist Gallwitz [email protected] This article was submitted to Molecular and Structural Endocrinology, a section of the journal Frontiers in Endocrinology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Goldin E, Ardite E, Elizalde JI, Odriozola A, Panes J, Pique JM, and Fernndez-Checa JC (1997)